Evaluation of Outcomes of Peritoneal Dialysis Patients in the Post-COVID-19 Period: A National Multicenter Case-Control Study from Turkey

Basit Öğe Kaydı
dc.authoridDolarslan, Murside Esra/0000-0002-8669-4212
dc.authoridSahin, Idris/0000-0002-8683-3737
dc.authoridAri Bakir, Elif/0000-0001-9208-7972
dc.authoridOruç, Ayşegül/0000-0002-0342-9692
dc.authoridBakirdogen, Serkan/0000-0002-3448-0490
dc.authoridARICI, MUSTAFA/0000-0002-4055-7896
dc.authoridkoyuncu, sumeyra/0000-0002-1159-5818
dc.authorwosidDolarslan, Murside Esra/D-5535-2019
dc.authorwosidSahin, Idris/AAS-4390-2020
dc.authorwosidAri Bakir, Elif/HJH-3482-2023
dc.authorwosidOruç, Ayşegül/AAH-4002-2021
dc.authorwosidBakirdogen, Serkan/ABI-3906-2020
dc.authorwosidYazici, Halil/AAE-3502-2020
dc.authorwosidARICI, MUSTAFA/I-9265-2013
dc.contributor.authorOzturk, Savas
dc.contributor.authorGursu, Meltem
dc.contributor.authorArici, Mustafa
dc.contributor.authorSahin, Idris
dc.contributor.authorEren, Necmi
dc.contributor.authorYilmaz, Murvet
dc.contributor.authorKoyuncu, Sumeyra
dc.date.accessioned2024-08-04T20:53:06Z
dc.date.available2024-08-04T20:53:06Z
dc.date.issued2023
dc.departmentİnönü Üniversitesien_US
dc.description.abstractIntroduction: There are not enough data on the post-CO-VID-19 period for peritoneal dialysis (PD) patients affected from COVID-19. We aimed to compare the clinical and laboratory data of PD patients after COVID-19 with a control PD group. Methods: This study, supported by the Turkish Society of Nephrology, is a national, multicenter retrospective case-control study involving adult PD patients with confirmed COVID-19, using data collected from April 21, 2021, to June 11, 2021. A control PD group was also formed from each PD unit, from patients with similar characteristics but without COVID-19. Patients in the active period of COVID-19 were not included. Data at the end of the first month and within the first 90 days, as well as other outcomes, including mortality, were investigated. Results: A total of 223 patients (COVID-19 group: 113, control group: 110) from 27 centers were included. The duration of PD in both groups was similar (median [IQR]: 3.0 [1.88-6.0] years and 3.0 [2.0-5.6]), but the patient age in the COVID-19 group was lower than that in the control group (50 [IQR: 40-57] years and 56 [IQR: 46-64] years, p < 0.001). PD characteristics and baseline laboratory data were similar in both groups, except serum albumin and hemoglobin levels on day 28, which were significantly lower in the COVID-19 group. In the COVID-19 group, respiratory symptoms, rehospitalization, lower respiratory tract infection, change in PD modality, UF failure, and hypervolemia were significantly higher on the 28th day. There was no significant difference in laboratory parameters at day 90. Only 1 (0.9%) patient in the COVID-19 group died within 90 days. There was no death in the control group. Respiratory symptoms, malnutrition, and hypervolemia were significantly higher at day 90 in the COVID-19 group. Conclusion: Mortality in the first 90 days after COVID-19 in PD patients with COVID-19 was not different from the control PD group. However, some patients continued to experience significant problems, especially respiratory system symptoms, malnutrition, and hypervolemia.en_US
dc.identifier.doi10.1159/000526234
dc.identifier.endpage280en_US
dc.identifier.issn1660-8151
dc.identifier.issn2235-3186
dc.identifier.issue5en_US
dc.identifier.pmid36183694en_US
dc.identifier.scopus2-s2.0-85141223805en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage272en_US
dc.identifier.urihttps://doi.org/10.1159/000526234
dc.identifier.urihttps://hdl.handle.net/11616/100976
dc.identifier.volume147en_US
dc.identifier.wosWOS:000892742500001en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherKargeren_US
dc.relation.ispartofNephronen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCOVID-19en_US
dc.subjectPeritoneal dialysisen_US
dc.subjectOutcomeen_US
dc.subjectComplicationen_US
dc.titleEvaluation of Outcomes of Peritoneal Dialysis Patients in the Post-COVID-19 Period: A National Multicenter Case-Control Study from Turkeyen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu